1. Research Infrastructures
  2. Antiviral Drug Design Platform

Antiviral Drug Design Platform

CONTACT
Coordinates 43.29236346203756, 5.359133426541125
Contact name Jean-Claude Guillemot
CIVIS Label No
Acronym AD2P-PTA
Scientific domain

LS1_11 - Chemical biology - Molecules of Life: Biological Mechanisms, Structures and Functions


 

LS7_9 - Public health and epidemiology - Prevention, Diagnosis and Treatment of Human Diseases


 

LS6_6 - Infectious diseases - Immunity, Infection and Immunotherapy


 

LS8_4 - Population biology, population dynamics, population genetics - Environmental Biology, Ecology and Evolution


 

LS9_2 - Applied genetics, gene editing and transgenic organisms - Biotechnology and Biosystems Engineering


Keywords

HTS


 

Antivirals


 

Emerging Viruses


 

2P2I


Partner institution

Aix-Marseille Université


Website No
Technical staff available No
Remote access details AD2P is accessible to scientific communities of both the academic and private sectors, upon request.
Remote access available No
Open to external users No
Equipment Here below are examples of the services ADP2 can provide: -screening of antivirals against emerging viruses e.g., Dengue, Zika , WNV, Chik , VEEV, SARS, MERS, TBE, JEV, -screening against clinical virus isolates-development of new antiviral strategies e.g., HTRF, 2P2I, -structure based drug design, -cheminformatics, and creation of chemolibraries, -Hit to Lead optimisation
Open access to updated information database No
Online booking system details Charte des Plateformes Technologiques Aix-Marseille (PTA): https://www.univ-amu.fr/system/files/2021-07/Charte%20PTF%20AMU%20M%C3%A0J21.docx.pdf
Online booking system available No
Description AD2P (also locally refered as 'Plateforme de Criblage Marseille-Luminy = PCML) plays a significant role in the research field of antivirals against emerging viruses. Indeed, the facility has developed and offers expertise in the screening of viral enzyme inhibitors, protein/protein interactions, clinical virus isolates, the supply of chemical libraries, as well as in the development of new technologies and drug design.